Butyrate suppresses abnormal proliferation in colonic epithelial cells under diabetic state by targeting HMGB1
Butyrate is widely accepted as a proliferation inhibitor in colon cancer but less thoroughly characterized in the colonic epithelium of objects with type 2 diabetes mellitus. The present study investigated the regulatory effect of butyrate on proliferation, the related molecule high-mobility group b...
Main Authors: | Si-Yi Wang, Jie-Yao Li, Ji-Hao Xu, Zhong-Sheng Xia, Di Cheng, Wa Zhong, Yu Lai, Tao Yu, Qi-Kui Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-04-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861318301634 |
Similar Items
-
Cordycepin inhibits colon cancer proliferation by suppressing MYC expression
by: Zhe Zhang, et al.
Published: (2022-02-01) -
Inhibition of HMGB1/RAGE axis suppressed the lipopolysaccharide (LPS)-induced vicious transformation of cervical epithelial cells
by: Lifang You, et al.
Published: (2021-01-01) -
Sodium Butyrate Ameliorates Streptozotocin-Induced Type 1 Diabetes in Mice by Inhibiting the HMGB1 Expression
by: Yu Guo, et al.
Published: (2018-10-01) -
Recombined humanized endostatin‐induced suppression of HMGB1 expression inhibits proliferation of NSCLC cancer cells
by: Fan‐Jie Meng, et al.
Published: (2019-01-01) -
Suppression of Berberine and Probiotics (in vitro and in vivo) on the Growth of Colon Cancer With Modulation of Gut Microbiota and Butyrate Production
by: Chao Huang, et al.
Published: (2022-04-01)